Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Hearing aid pill? study tests donepezil for cochlear implant users

NCT ID NCT05438264

First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 23 times

Summary

This study tests whether donepezil, a drug used for memory, can improve speech understanding in adults with cochlear implants. The idea is that the drug may help the brain adapt to the implant's signals. Fifty participants will receive either donepezil or a placebo for 3 months, and their hearing and thinking skills will be measured.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BILATERAL SENSORINEURAL HEARING LOSS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37203, United States

Conditions

Explore the condition pages connected to this study.